Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature

Abstract Background The sodium-glucose cotransporter-2 (SGLT2) inhibitors are the newest class of anti-hyperglycemic medications used in the treatment of diabetes mellitus. Their increasing use has been driven by their apparent cardiovascular and renal benefits. They have been associated with a smal...

Full description

Bibliographic Details
Main Authors: Alexis Diaz-Ramos, Wesley Eilbert, Diego Marquez
Format: Article
Language:English
Published: BMC 2019-09-01
Series:International Journal of Emergency Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12245-019-0240-0